New Confirmed Cases 1,375... First Dose Vaccination Rate 58.4% (Update)

1351 Local Cases, 24 Imported Cases
69.6% of Confirmed Cases in the Seoul Metropolitan Area

On the 6th, as the large-scale spread of COVID-19 continued, citizens were waiting for tests at the temporary screening site in Seoul Station Plaza. According to the Central Disease Control Headquarters of the Korea Disease Control and Prevention Agency, as of midnight that day, the number of confirmed cases increased by 1,375 from the previous day to 261,778. The daily number of patients during the 4th wave has been in the four digits for 62 consecutive days since July 7. Photo by Hyunmin Kim kimhyun81@

[Asia Economy Reporter Kim Ji-hee] The number of new COVID-19 cases in South Korea has remained in the four digits for 62 consecutive days.

According to the Central Disease Control Headquarters, as of midnight on the 6th, the cumulative number of COVID-19 cases increased by 1,375 from the previous day, reaching a total of 261,778. Of these, 1,351 cases were locally transmitted, and 24 were imported.

In the metropolitan area, local cases were recorded as 462 in Seoul, 398 in Gyeonggi, and 80 in Incheon, totaling 940 cases. Metropolitan area cases accounted for 69.6% of the total. In non-metropolitan areas, cases were reported as follows: 61 in Chungnam, 57 in Gyeongnam, 51 in Busan, 42 in Daegu, 38 in Ulsan, 37 in Gyeongbuk, 29 in Daejeon, 27 in Gwangju, 9 in Jeju, 7 in Jeonbuk, and 4 each in Jeonnam and Sejong.

The total number of tests conducted in one day was limited to 90,000. At temporary screening clinics set up in the metropolitan area, 42,951 tests were conducted, confirming 234 positive cases, while 13,946 tests were conducted at non-metropolitan temporary screening clinics, confirming 59 positive cases.

The number of critically ill patients decreased by 5 from the previous day, totaling 358. The cumulative death toll increased by 6 to 2,327.

Meanwhile, according to the COVID-19 Vaccination Response Promotion Team, 8,305 people received their first vaccine dose the previous day. The cumulative number of first-dose recipients reached 30,005,459, with a first-dose vaccination rate of 58.4%. Additionally, 7,984 people completed their vaccination, bringing the total number of fully vaccinated individuals to 17,751,820, representing a completion rate of 34.6% of the population.

Reports of suspected adverse reactions following vaccination increased by 2,451 over two days, reaching a cumulative total of 192,559 cases. Common symptoms such as muscle pain, headache, fever, chills, and nausea accounted for 184,229 cases (95.7%) of the total. Among the newly reported adverse reactions, there were 7 suspected cases of anaphylaxis, 56 neurological adverse reactions, and 4 deaths.

This content was produced with the assistance of AI translation services.